Skip to main navigation News Releases Piper Sandler Virtual Healthcare Conference Tuesday, November 23, 2021 at 7:00 AM EST Click here for webcast Keyword Search Year 2021 Date Title 11/23/21 Optinose to Present at the Piper Sandler Virtual Healthcare Conference 11/18/21 Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 11/18/21 Optinose Announces Closing of $46.0 Million Public Offering of Common Stock 11/16/21 Optinose Announces Pricing of Public Offering of Common Stock 11/15/21 Optinose Announces Proposed Public Offering of Common Stock 11/15/21 Optinose Reports Third Quarter 2021 Financial Results and Recent Operational Highlights 11/10/21 Optinose Announces Reporting Date for Third Quarter 2021 Financial Results 10/28/21 Optinose Completes Patient Recruitment in Second Pivotal Trial for XHANCE in Chronic Sinusitis 09/22/21 Optinose to Present at the Cantor Virtual Global Healthcare Conference 08/25/21 Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 08/11/21 Optinose Reports Second Quarter 2021 Financial Results and Recent Operational Highlights 07/30/21 Optinose Completes Patient Recruitment in Pivotal Trial for XHANCE in Chronic Sinusitis 07/28/21 Optinose Announces Preliminary Second Quarter 2021 XHANCE Net Revenue of $18.4 Million 06/24/21 Optinose Technology Inventor Per Djupesland Named Winner of European Inventor Award 2021 for Industry 06/02/21 Experts Issue New Treatment Algorithm for Chronic Rhinosinusitis with Nasal Polyps That Highlights Role of XHANCE® In Stepwise Care 06/01/21 Optinose to Present at the Jefferies Virtual Healthcare Conference 05/05/21 Optinose Reports First Quarter 2021 Financial Results and Operational Updates 04/28/21 Optinose Announces Reporting Date for First Quarter 2021 Financial Results and Upcoming Healthcare Conference Presentation 04/27/21 New Harris Survey Reveals Chronic Nasal Congestion Is Surprisingly Widespread: Nearly 1 in 4 Americans With Nasal Congestion Experience Symptoms Almost Every Day 04/12/21 Optinose to Present at the Needham Virtual Healthcare Conference 03/03/21 Optinose Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights 02/17/21 Optinose Announces Reporting Date for Fourth Quarter 2020 Financial Results 01/25/21 Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Investors News & Events News Releases Event Calendar Presentations Stock Information Corporate Governance SEC Filings Proxy Materials Investor Resources Toolkit Print page Sign up for email alerts Investor Contact Jonathan Neely VP Investor Relations and Business Operations Email: investors@optinose.com Contact Us P.O. Terms & Conditions Join Our Team Privacy Policy Terms of Use Site Map ©2021 Optinose. OPTINOSE-17-013a 09/2017